Join
Live feed
·
INSIDERFilingvia Quantisnow
Cartesian Therapeutics Inc. logo

Director Springer Timothy A bought $7,373,527 worth of shares (431,940 units at $17.07), increasing direct ownership by 5% to 8,455,706 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNAC· Cartesian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAC (Cartesian Therapeutics Inc.) and more on Quantisnow.